Dr. Yogarajah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12277 De Paul Dr
Ste 100
Bridgeton, MO 63044Phone+1 314-209-5142
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2018 - 2019
- Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2015 - 2018
- One Brooklyn Health System/Interfaith Medical CenterResidency, Internal Medicine, 2012 - 2015
Certifications & Licensure
- MO State Medical License 2019 - 2025
- NJ State Medical License 2022 - 2025
- MN State Medical License 2018 - 2020
- NC State Medical License 2015 - 2019
- NY State Medical License 2015 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 13 citationsHemophagocytic lymphohistiocytosis (HLH) secondary to Ehrlichia chaffeensis with bone marrow involvement.Abdul Rafeh Naqash, Meera Yogarajah, Bethany Dawn Vallangeon, Maida Hafiz, Deval Patel
Annals of Hematology. 2017-07-31 - 77 citationsLeukemic Transformation in Myeloproliferative Neoplasms: A Literature Review on Risk, Characteristics, and OutcomeMeera Yogarajah, Ayalew Tefferi
Mayo Clinic Proceedings. 2017-07-01 - 100 citationsBlast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohortsAyalew Tefferi, Mythri Mudireddy, Francesco Mannelli, Kebede H. Begna, Mrinal M. Patnaik
Leukemia. 2018-02-02
Lectures
- Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Discrepancy of blast percentage between the bone marrow aspirate and biopsy and its impact on survival outcomes in patients with myelodysplastic syndromes excess blast...2019 ASCO Annual Meeting - 6/1/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: